Medicine Management Services (Pty) Ltd and Gerard Augustine t/a Direct Medicines Pharmacy (63/LM/Jul05) [2005] ZACT 60 (14 September 2005)

60 Reportability
Competition Law

Brief Summary

Competition Law — Merger Approval — Unconditional approval of merger between Medicine Management Services (Pty) Ltd and Direct Medicines Pharmacy — The Competition Tribunal found that the merger would not substantially lessen competition in the market for dispensing prescription medicines to private sector patients, as there was no overlap in activities and the parties' combined market share was minimal — The Tribunal concluded that the merger posed no negative impact on employment and was therefore approved unconditionally.

COMPETITION TRIBUNAL 
REPUBLIC OF SOUTH AFRICA
     Case No: 63/LM/Jul05
In the large merger between: 
Medicine Management Services (Pty) Ltd
and
Gerard Augustine  t/a  Direct Medicines Pharmacy 
Reasons for Decision
APPROVAL
1. On 24 August 2005 the Competition Tribunal issued a Merger Clearance  
Certificate   unconditionally   approving   the   merger   between   Medicine  
Management   Services   (Pty)   Ltd   and   Direct   Medicines   Pharmacy.     The  
reasons for the approval of the merger appear below.
The Parties
2. The acquiring firm is Medicine Management Services  
(Pty)   Ltd   (“MMS”),   a   subsidiary   of   Afrox   Healthcare  
Services (Pty) Ltd. 1  
3. The target firm is the dispensary business of Gerald Augustine trading as  
1     The      following three (3) entities control MMS, viz., Afrox Healthcare Services (Pty) Ltd (which holds     
100% of the issued share capital of MMS);  Afrox Healthcare Ltd (which recently changed its name to Life  
Healthcare (Pty) Ltd; and Business Venture Investments 790 (Pty) Ltd (wh ich recently acquired the 100%  
of the issued share capital of Life ).

Direct   Medicines   Pharmacy   (“the   Pharmacy   Business”),   which   is  
controlled   by   MMS   (as   its   administrator   and   manager)   and   Gerard  
Augustine (as its sole shareholder). 2  
The merger transaction
4. Both Gerard Augustine t/a Direct Medicines Pharmacy and MMS entered  
into a Sale of Business Agreement in terms of which MMS acquired the  
pharmacy business as a going concern.  Subsequent to the implementation of  
the merger, sole control (on a direct basis) over the pharmacy business will vest  
in MMS. 3 
5.
Rationale for the Transaction
5. Owing   to   the   recent   amendments   to   the   Regulations   relating   to   the  
Ownership and Licensing of Pharmacies it was no longer obligatory for  
Gerard Augustine, who is a registered pharmacist, to run the pharmacy  
business.   Having regard to his desire to exit the pharmacy business it  
was   decided   to   consolidate   the   pharmacy   business’   administration,  
management and dispensing operations into MMS. 4 
2    MMS exercises administrative and managerial control over the Pharmacy Business, and do not  
directly or indirectly control any other firm. Mr Augustine does not control (directly or indirectly)  
any firm save for holding all of the issued share capital of Direct Medicines (Pty) Ltd, a dormant  
company. (See page 14 (item 2.2) of the record).
3    Page 25 (item 11.3) of the record.
4  See page 3 of the transcript dated 24 August 2005 as well as p age 45 of the record .
  2

The relevant product market
6. MMS   undertakes   administration   and   managerial   services   for   Direct  
Medicines. Direct Medicines in turn conducts the business of dispensing  
prescription medicines to private sector patients.   The parties contended  
that the relevant product market for analyzing the proposed merger is the  
market   for   the   dispensing   of   prescription   medicines   to   private   sector  
patients.
7. We found that no overlap exists with respect to activities of the merging  
parties.  
Retail Pharmaceutical (Dispensary) products
The relevant geographic market
8. Since   the   pharmacy   business   conducts   the   business   of   dispensing  
prescription medicines to private sector patients throughout South Africa,  
the market is defined as national. 
Impact on competition
9.
A
9. ccording to the merging parties the total number of repeat prescriptions in  
South   Africa   on   a   monthly   basis   amounts   to   approximately   1.4   million  
repeat   prescriptions   of   which   the   pharmacy   business’   market   share  
  3

accounted  for   0.05%.     The  proposed  merger   would   not   give  rise  to  an  
aggregation of market shares because MMS is not involved in this market.  
10. We are persuaded that the merger is unlikely to result in the substantial  
lessening   or   prevention   of   competition   given   the   significant   number   of  
players in the market as well as the merging parties’ low market shares  
post­merger.  were compounded by the prospect that might not enter this  
sector at all
.
“It is clear that the existence of Proctor at the edge of the industry  
exerted   considerable   influence   on   the   market.   First,   the   market  
behaviour   of   the   liquid   bleach   industry   was   influenced   by   each  
firm’s predictions of the market behaviour of its competitors, actual  
and potential. Second, the barriers to entry by a firm of Proctor’s  
size and with its advantages were not significant…”
­– 
.
.
Public Interest
11. The   merging   parties   were   confident   that   there   would   be   no   negative  
effects on employment arising from the proposed merger as no job losses  
were anticipated.
Conclusion
12. The proposed merger is therefore approved unconditionally. 
  4

__________            14 September 2005  
N. Manoim      Date
Concurring: M. Moerane, M. Mokuena
For the merging parties:   Mark Garden,  Edward Nathan Corporate Law  
Advisers 
For the Commission:  Odie Strydom assisted by Leonard Lamola,  Mergers  
& Acquisitions
  5